P295: Early sonographic improvement predicts the middle-term efficacy of molecular-targeted medications for Ulcerative ColitisECCO'24Year: 2024
Authors: Miyoshi, J.(1)*;Kimura, Y.(1);Morikubo, H.(1);Komatsu, H.(1);Yonezawa, H.(1);Matsuura, M.(1);Hisamatsu, T.(1);
(1)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Mitaka-shi, Japan;
P296: Preclinical protein signatures in blood predict Crohn@E@s disease and Ulcerative colitis several years before the diagnosisECCO'24Year: 2024
Authors: Grännö, O.(1)*;Salomon, B.(2);Lindqvist, C.M.(2);Hedin, C.R.H.(3);Carlson, M.(4);Dannenberg, K.(2);Andersson, E.(5);Söderholm, J.D.(6);Keita, Å.V.(7);Öhman, L.(8);Magnusson, M.K.(8);D’Amato, M.(9);Eriksson, C.(5);Hultdin, J.(10);Kruse, R.(2);Cao, Y.(11);Repsilber, D.(2);Bergemalm, D.(5);Grip, O.(12);Karling, P.(13);Halfvarson, J.(5);
(1)Örebro University, Faculty of Medicine and Health- Department of Laboratory Medicine- Clinical Microbiology, Örebro, Sweden;(2)Örebro University, Faculty of Medicine and Health- School of Medical Sciences, Örebro, Sweden;(3)Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden;(4)Uppsala University, Department of Medical Sciences- Gastroenterology Research Group, Uppsala, Sweden;(5)Örebro University, Department of gastroenterology- Faculty of Medicine and Health, Örebro, Sweden;(6)Linköping University, Department of Surgery, Linköping, Sweden;(7)Linköping University, Department of Biomedical and Clinical Sciences, Linköping, Sweden;(8)Sahlgrenska Academy- University of Gothenburg, Department of Microbiology and Immunology- Institute of Biomedicine, Göteborg, Sweden;(9)CIC BioGUNE–BRTA, Gastrointestinal Genetics Lab, Derio, Spain;(10)Umeå University, Department of Medical Biosciences- Clinical Chemistry, Umeå, Sweden;(11)Örebro University, Clinical Epidemiology and Biostatistics- School of Medical Sciences- Faculty of Medicine and Health, Örebro, Sweden;(12)Skåne University Hospital, Department of Gastroenterology, Malmö, Sweden;(13)Umeå University, Department of Public Health and Clinical Medicine, Umeå, Sweden;BIOIBD consortium
P297: Differences in disease characteristics and treatment exposures between pediatric- and adult-onset Ulcerative ColitisECCO'24Year: 2024
Authors: Granot, M.(1)*;Kopylov, U.(2);Nachum, N.(1);Krauthammer , A.(1);Abitbol, C.M.(2);Ben Horin, S.(2);Weiss, B.(1);Haberman, Y.(1);
(1)Sheba Medical Center- Tel-HaShomer, Pediatric Gastroenterology and Nutrition Unit, Ramat Gan, Israel;(2)Sheba Medical Center- Tel-HaShomer, Department of Gastroenterology, Ramat Gan, Israel;
P298: Adherence to diagnostic and treatment recommendations for the management of acute severe ulcerative colitis: a prospective and multinational studyECCO'24Year: 2024
Authors: Rodríguez-Lago, I.(1)*;Frasson, M.(2);Pinkney, T.(3);Blackwell, S.(4);Gecse, K.(5);Buskens, C.(6);Knowles, C.(7);Zmora, O.(8);Brookes, M.(9);Fiorino, G.(10);Nos, P.(11);Gallo, G.(12);Pata, F.(13);Verjee, A.(14);Leone, S.(15);Pellino, G.(16);P. Gisbert, J.(17);
(1)Hospital Universitario de Galdakao, Gastroenterology, Galdakao, Spain;(2)Hospital Universitario y Politécnico La Fe, Colorectal Surgery, Valencia, Spain;(3)Queen Elizabeth Hospital- University of Birmingham, Academic Department of Surgery, Birmingham, United Kingdom;(4)Patient representative, Patient representative, Liverpool, United Kingdom;(5)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;(7)Queen Mary University of London- Blizard Institute Knowles, Centre for Neuroscience- Surgery & Trauma, London, United Kingdom;(8)Assaf Harofeh Medical Center, Division of General Surgery, Zerifin, Israel;(9)Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, United Kingdom;(10)IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Gastroenterology and Endoscopy, Milan, Italy;(11)Hospital Universitario y Politécnico La Fe, Gastroenterology, Valencia, Spain;(12)Sapienza University of Rome, Surgical Sciences, Rome, Italy;(13)Nicola Giannettasio Hospital, General Surgery Unit, Corigliano-Rossano, Italy;(14)Patient representative, Patient representative, London, United Kingdom;(15)AMICI Italia Onlus, Patient representative, Milan, Italy;(16)Università degli Studi della Campania @D@Luigi Vanvitelli@D@, Advanced Medical and Surgical Sciences, Naples, Italy;(17)Hospital Universitario de La Princesa - Instituto de Investigación Sanitaria Princesa - Universidad Autónoma de Madrid, Gastroenterology, Madrid, Spain;On behalf of MASC (Management of Acute Severe Colitis) collaborating group and ESCP (European Society of Coloproctology) Cohort Studies Group.
P300: An Expert Delphi Consensus: Early Identification of Patients at Risk of Crohn@E@s Disease in Perianal Fistulas and Abscesses (PREFAB) and Identification and Management of Isolated Perianal Crohn@E@s Disease (ipCD) - Part A, PREFABECCO'24Year: 2024
Authors: Munster, L.(1)*;Hanna, L.N.(2);Dige, A.(3);Lundby, L.(4);Hart, A.L.(2);Buskens, C.J.(5);Tozer, P.J.(6);van der Bilt, J.D.W.(1);
(1)Flevoziekenhuis/Amsterdam UMC- location AMC, Surgery, Amsterdam, The Netherlands;(2)St. Mark@E@s Hospital, Gastroenterology and Hepatology, London, United Kingdom;(3)Aarhus University Hospital, Gastroenterology and Hepatology, Aarhus, Denmark;(4)Aarhus University Hospital, Surgery, Aarhus, Denmark;(5)Amsterdam UMC- location AMC, Surgery, Amsterdam, The Netherlands;(6)St. Mark@E@s Hospital, Surgery, London, United Kingdom;
P301: Distinct plasma proteomic biomarkers associate with disease progression in patients with Inflammatory Bowel DiseasesECCO'24Year: 2024
Authors: Veenstra, F.E.(1);Hu, S.(1,2);van Dullemen, H.M.(1);Visschedijk, M.C.(1);Faber, K.N.(1);Dijkstra, G.(1);Samsom, J.N.(3);Festen, E.A.M.(1);Weersma, R.K.(1);Spekhorst, L.M.(1);Bourgonje, A.R.(4)*;
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)Sun-Yat Sen University, Institute of Precision Medicine, Guangzhou, China;(3)Erasmus University Medical Center, Division of Gastroenterology, Rotterdam, The Netherlands;(4)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;
P302: Diagnostic Delayed is Associated with a Poor Prognosis in Patients with Crohn@E@s DiseaseECCO'24Year: 2024
Authors: Kiliç, V.(1)*;Kivrakoglu, F.(2);Ergin, M.(3);Kucuk, H.(4);Yuksel, I.(5,6);
(1)Batman Education and Research Hospital, Gastroenterology, Batman, Turkey;(2)Osmaniye State Hospital, Gastroenterology, Osmaniye, Turkey;(3)Aksaray Education and Research Hospital, Gastroenterology, Aksaray, Turkey;(4)Mardin Education and Research Hospital, Gastroenterology, Mardin, Turkey;(5)Ankara Bilkent City Hospital, Gastroenterology, Ankara, Turkey;(6)Ankara Yildirim Beyazit University School of Medicine, Gastroenterology, Ankara, Turkey;
P303: Determining the threshold for moderate-to-severe disability in inflammatory bowel disease using IBD-DiskECCO'24Year: 2024
Authors: Kallel, H.(1)*;Elleuch, N.(1);Dahmeni, W.(1);Limam, R.(1);Hammami, A.(1);Braham, A.(1);Ksiaa, M.(1);Jaziri, H.(1);Ben Slama, A.(1);
(1)Sahloul Hospital, Gastroenterology Department, Sousse, Tunisia;
P304: Endoscopic cuffitis is associated with severe inflammatory pouch phenotypesECCO'24Year: 2024
Authors: Powers, J.(1)*;Westbrook, K.(2);Zemanek, M.(2);Dester, E.(1);Cohen, B.(3);Lashner, B.(3);Ivanov, A.(4);Hull, T.(5);Qazi, T.(3);
(1)Cleveland Clinic, Lerner College of Medicine, Cleveland, United States;(2)Cleveland Clinic, Department of Internal Medicine, Cleveland, United States;(3)Cleveland Clinic, Department of Gastroenterology- Hepatology- and Nutrition, Cleveland, United States;(4)Lerner Research Institute, Department of Inflammation and Immunity, Cleveland, United States;(5)Cleveland Clinic, Department of Colorectal Surgery, Cleveland, United States;
P305: The serum protein profile across the IBD spectrum: Results from the COLLIBRI consortiumECCO'24Year: 2024
Authors: Salomon, B.(1)*;Sudhakar, P.(2);Verstockt, B.(2,3);Ungaro, R.C.(4);Aden, K.(5);D@E@Haens, G.R.(6);Silverberg, M.S.(7);Repsilber, D.(1);Vermeire, S.(3);Halfvarson, J.(8);
(1)Örebro University, Faculty of Medicine and Health- School of Medical Sciences, Örebro, Sweden;(2)KU Leuven, Department of Chronic Diseases- Metabolism and Ageing- Translational Research Center for Gastrointestinal Disorders, Leuven, Belgium;(3)KU Leuven, Department of Gastroenterology and Hepatology- University Hospitals Leuven, Leuven, Belgium;(4)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(5)Christian-Albrechts-University of Kiel and University Hospital Schleswig-Holstein, Institute of Clinical Molecular Biology, Kiel, Germany;(6)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(7)Mount Sinai Hospital, Inflammatory Bowel Disease Centre, Toronto-ON, Canada;(8)Örebro University- Faculty of Medicine and Health, Department of Gastroenterology, Örebro, Sweden;on the behalf of the COLLIBRI consortium
P306: Rectal bleeding and stool frequency are strong predictors of endoscopic and histologic activity in ulcerative colitis patients, a prospective cohort study.ECCO'24Year: 2024
Authors: Alenezi , T.(1);Almushir , S.(2);Afif , W.(1);Wild , G.(1);Lakatos , P.(1);Brassard , P.(1);Bitton , A.(1);Bessissow , T.(1)*;
(1)McGill University Health Center, Gastroenterology, Montreal, Canada;(2)McGill University Health Center, Internal medicine, Montreal, Canada;
P307: Novel proteomic analysis of 11,000 serum proteins distinguishes between Crohn’s disease and ulcerative colitis in pediatric patientsECCO'24Year: 2024
Authors: Wu, M.C.(1);Dillon, S.(2);Omede, M.(1);Gu, X.(2);Otu, H.(3);Ngo, L.(2);Winter, H.(1);Libermann, T.(2)*;
(1)Massachusetts General Hospital, Pediatrics, Boston, United States;(2)Beth Israel Deaconess Medical Center, Medicine, Boston, United States;(3)University of Nebraska–Lincoln, Electrical and Computer Engineering, Lincoln, United States;
P308: CPa9-HNE: A NEUTROPHIL-DERIVED FRAGMENT OF CALPROTECTIN MEASURED IN SERUM CAN MONITOR ENDOSCOPIC AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITISECCO'24Year: 2024
Authors: Sorokina Alexdóttir, M.(1)*;Poulsen, A.(2);Pehrsson, M.(1);Seidelin, J.B.(3);Mortensen, J.H.(1);
(1)Nordic Bioscience, Biomarkers and Research, Herlev, Denmark;(2)Bispebjerg Hospital- University of Copenhagen-, Digestive Disease Center, Bispebjerg, Denmark;(3)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;
P309: Impact of EBV Status on decision making for advanced therapies in IBD PatientsECCO'24Year: 2024
Authors: Robertson, H.(1)*;Thut, J.(1);Turnbull, J.(1);Whitehead, E.(1);Fitzgerald, A.L.(1);McBride , J.(1);Savage, R.(1);Wilkinson, J.(1);Harper, P.(1);Rice, J.(1);Pattinson , A.(1);Bautista, N.(1);Sebastian, S.(1);
(1)Hull University Teaching Hospitals NHS Trust, Inflammatory Bowel Disease, Hull, United Kingdom;
P310: Intestinal ultrasound as a tool to assess treatment response in patients with Inflammatory Bowel DiseasesECCO'24Year: 2024
Authors: KatsarosMD, M.(1)*;Katsoula, A.(1);Kalogirou, M.(1);Paschos, P.(2);Papagiannakis, P.(1);Tsionis, T.(1);Giouleme, O.(1);
(1)Hippokration Hospital, Gastroenterology Division- Second Propaedeutic Department of Internal Medicine- Medical School- Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)@D@Papageorgiou@D@ Hospital, First Department of Internal Medicine, Thessaloniki, Greece;
P311: Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: a prospective cohort study.ECCO'24Year: 2024
Authors: Nuzzo, A.(1)*;Adam Hassan, F.(2);Dermine, S.(3);Mohamed Gouse, A.(2);Billiauws, L.(2);Bourdillel, J.(2);Joly, F.(2);
(1)Hospital Beaujon, Department of Gastroenterology- IBD and Intestinal Failure, Clichy, France;(2)Beaujon Hospital, Gastroenterology- IBD- Intestinal Failure, Clichy, France;(3)Beaujon Hospital, Gastroenteroloy- IBD- Intestinal Failure, Clichy, France;
P312: Questionnaire survey for IBD patients in Japan; A Web-based J-CUP SurveyECCO'24Year: 2024
Authors: Goda, Y.(1)*;Matsumoto, T.(2);Imai, K.(1);Fujimitsu, Y.(1);Kajioka, T.(1);Kihara, H.(1);Funaki, Y.(3);Imaki, S.(4);Ueno, M.(1);
(1)EA pharma, Department of IBD Strategy, Tokyo, Japan;(2)Iwate Medical University, Division of Gastroenterology- Department of Internal Medicine, Morioka, Japan;(3)EA Pharma, Department of Integrated Marketing, Tokyo, Japan;(4)EA Pharma, Department of Corporate Communication, Tokyo, Japan;
P313: Panenteric capsule endoscopy in the investigation and assessment of Crohn’s disease at a tertiary centreECCO'24Year: 2024
Authors: Angadi, N.(1)*;Badat , S.(1);Villa, M.(1);Edward, S.(1);Willsmore, J.(1);Paul , H.(1);Bloom , S.(1);McCartney, S.(1);Rahman, F.(1);Magee, C.(1);Parisi, I.(1);
(1)University College London Hospital, Department of Gastroenterology, London, United Kingdom;
